Agenus (AGEN) EBT Margin (2010 - 2026)

Agenus' (AGEN) quarterly EBT Margin came in at 1.08% in Q1 2026, up 11034.0% year-on-year from N/an in Q1 2025, and up 122.35% quarter-over-quarter from 4.83% in Q4 2025.

Agenus (AGEN) EBT Margin (2010 - 2026) Analysis & Trends

Agenus' EBT Margin history runs 17 years deep, the most recent figure standing at 1.08% for Q1 2026.

  • On a quarterly basis, EBT Margin rose 11034.0% year-over-year to 1.08% in Q1 2026; TTM through Mar 2026 was 30.93%, a 17408.0% increase from a year earlier, with the FY2025 full-year figure at 363.48%, up 13831.0% from the prior year.
  • EBT Margin improved to 1.08% in Q1 2026 per AGEN's latest filing, from 4.83% in the prior quarter.
  • Across five years, EBT Margin topped out at 130.93% in Q4 2022 and bottomed at 271.79% in Q3 2024.
  • The 5-year median for EBT Margin is 175.17% (2024), against an average of 132.92%.
  • Biggest YoY gain for EBT Margin was 99642 bps in 2022; the steepest drop was 23818 bps in 2022.
  • Year by year, EBT Margin stood at 130.93% in 2022, then slumped by 104 bps to 5.77% in 2023, then tumbled by 2935 bps to 175.17% in 2024, then soared by 97 bps to 4.83% in 2025, then soared by 122 bps to 1.08% in 2026.
  • Per Business Quant, the three latest AGEN EBT Margin figures stand at 1.08% (Q1 2026), 4.83% (Q4 2025), and 23.06% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 1.08%

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08%
Dec 31, 2025 -4.83%
Sep 30, 2025 -23.06%
Jun 30, 2025 -116.98%
Mar 31, 2025 -109.26%
Dec 31, 2024 -175.17%
Sep 30, 2024 -271.79%
Jun 30, 2024 -265.76%
Mar 31, 2024 -225.52%
Dec 31, 2023 -5.77%
Sep 30, 2023 -192.24%
Jun 30, 2023 -217.69%
Mar 31, 2023 -240.90%
Dec 31, 2022 130.93%
Sep 30, 2022 -185.51%
Jun 30, 2022 -215.83%
Mar 31, 2022 -141.32%
Dec 31, 2021 -272.77%
Sep 30, 2021 52.66%
Jun 30, 2021 -1,212.25%